Armodafinil is a wakefulness-promoting medicine used in some countries for adults experiencing excessive sleepiness associated with certain diagnosed sleep disorders. It is closely related to modafinil but is a distinct active substance containing the R-enantiomer of modafinil.
Importantly for UK readers, armodafinil should not be presented as though it were a routinely UK-licensed equivalent of modafinil. Current UK medicine listings include licensed modafinil products, whereas armodafinil products are authorised in other jurisdictions, including the United States.
People searching for Armodafinil tablets or Armodafinil online in the UK should therefore understand that availability and regulatory approval differ between countries. A healthcare professional should assess excessive sleepiness before wakefulness-promoting medicines are considered.
Important: Armodafinil should only be used when clinically appropriate and under the direction of a suitably qualified healthcare professional.
What Is Armodafinil?
Armodafinil is a wakefulness-promoting agent. Chemically, it is the R-enantiomer of modafinil. Modafinil contains both R- and S-enantiomers, whereas armodafinil contains the R-form.
In the United States, armodafinil is available as a prescription medicine and is marketed under the brand name Nuvigil as well as in generic forms. It is authorised to improve wakefulness in adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnoea or shift work disorder.
This does not mean those indications automatically apply as UK-approved uses. Medicine authorisations are jurisdiction-specific.
Armodafinil promotes wakefulness rather than providing a substitute for normal sleep or treating every underlying cause of excessive daytime sleepiness.
Armodafinil Strengths and UK Availability
Official US prescribing information lists Armodafinil tablets in 50mg, 150mg, 200mg and 250mg strengths. Different manufacturers and markets may offer different presentations.
These strengths should not be described as standard UK-authorised Armodafinil strengths. At present, current UK electronic Medicines Compendium searches identify licensed modafinil products in 100mg and 200mg strengths rather than an equivalent UK-authorised armodafinil product.
Patients should not substitute armodafinil for modafinil, or vice versa, simply because the names and pharmacology are related.
Where an unlicensed medicine is considered clinically necessary in the UK, its prescribing and supply involve different considerations from those applying to an ordinary licensed medicine.
What Is Armodafinil Used For?
In the United States, armodafinil is authorised to improve wakefulness in adults with excessive sleepiness associated with the following:
- Narcolepsy
- Obstructive sleep apnoea (OSA)
- Shift work disorder
Narcolepsy is a neurological sleep disorder that can cause significant daytime sleepiness and an increased tendency to fall asleep unexpectedly.
Obstructive sleep apnoea involves repeated interruption of breathing during sleep. Importantly, armodafinil’s US indication in OSA relates to excessive sleepiness and does not treat the underlying airway obstruction.
Shift work disorder can occur when a person’s work schedule conflicts with the body’s normal sleep-wake cycle.
These are US-authorised indications and should not be interpreted as UK marketing-authorisation claims.
How Does Armodafinil Work?
The precise mechanism responsible for armodafinil’s wakefulness-promoting effects is not thoroughly understood.
Armodafinil has pharmacological properties similar to modafinil. Research indicates that its effects involve pathways responsible for regulating wakefulness, including those associated with dopamine signalling.
Armodafinil and modafinil are not conventional amphetamine stimulants, although some of their wake-promoting actions share characteristics with sympathomimetic agents.
Armodafinil does not simply provide additional energy. Instead, it affects neurological systems involved in maintaining wakefulness.
Because excessive sleepiness can have numerous causes, including inadequate sleep, medicines and underlying medical conditions, proper evaluation of persistent symptoms remains important rather than assuming that a wakefulness-promoting medicine is appropriate.
How Should Armodafinil Be Taken?
Armodafinil tablets are taken orally. Exact administration depends on why treatment has been prescribed and the instructions provided by the responsible healthcare professional.
Official US prescribing information provides different timing recommendations according to the diagnosed sleep disorder. Patients should therefore follow their individual dispensing instructions rather than adopting dosing information found online.
Food can affect how quickly peak concentrations are reached, although overall absorption is not necessarily affected in the same way.
Patients should not independently increase their dose when they continue to experience sleepiness. Persistent or worsening sleepiness requires clinical reassessment.
Taking more than the prescribed amount can be dangerous. Suspected overdose requires urgent medical assessment because neurological, psychiatric, digestive and cardiovascular symptoms can occur.
How Long Is Armodafinil Normally Used?
There is no single treatment duration appropriate for everyone taking armodafinil. Duration depends on the diagnosed sleep disorder, continuing symptoms, response to treatment and ongoing clinical assessment.
A healthcare professional should periodically assess whether treatment remains necessary and whether excessive sleepiness is being adequately controlled.
Armodafinil should not be used as a way to compensate routinely for insufficient sleep.
Patients should also tell their healthcare professional if they develop an urge to increase the amount taken or begin using the medicine differently from the way it was prescribed.
Side Effects of Armodafinil
Like other medicines, armodafinil can cause side effects, although not everyone taking it will experience them.
Frequently reported adverse reactions in clinical studies have included:
- Headache
- Nausea
- Dizziness
- Difficulty sleeping
Other reactions can occur, and patients should consult the information supplied with their particular medicine.
Of particular importance are serious skin and hypersensitivity reactions. Serious rashes, including Stevens-Johnson syndrome, have been reported in association with armodafinil. Multi-organ hypersensitivity reactions and serious allergic reactions, including angioedema and anaphylaxis, are also included in official warnings.
New psychiatric symptoms can also occur. Particular caution is advised for people with a history of depression, mania or psychosis.
A new rash, blistering or peeling skin, mouth sores, facial or throat swelling, difficulty breathing or other signs of a severe reaction require urgent medical assessment.
Armodafinil, Driving and Persistent Sleepiness
Armodafinil is intended to improve wakefulness, but treatment does not guarantee that sleepiness will completely disappear.
People with significant excessive sleepiness should be regularly assessed, and they may need to avoid driving or other potentially hazardous activities until their level of wakefulness is considered adequate.
Armodafinil itself may also cause dizziness or other effects that could interfere with safe activities.
Patients should not assume that taking a wakefulness-promoting medicine automatically makes driving safe. The underlying sleep disorder and the person’s response to treatment both matter.
Medicines That May Interact With Armodafinil
Armodafinil can affect enzymes involved in processing other medicines and may therefore alter their concentrations or effects.
Potentially important interactions include the following:
- Hormonal contraceptives
- Anticonvulsant medicines
- Immunosuppressants
- Benzodiazepines
- Proton-pump inhibitors
- Antidepressants
Armodafinil can reduce the effectiveness of steroidal contraceptives during treatment and for a period after discontinuation. Alternative or additional contraceptive precautions may therefore be necessary according to professional advice.
It can also influence CYP3A4/5 and CYP2C19 pathways, which are involved in the metabolism of numerous medicines.
Patients should give their prescriber a complete list of prescription medicines, non-prescription products, vitamins and supplements before starting treatment.
Who Should Not Take Armodafinil?
Armodafinil is contraindicated under US prescribing information for people with known hypersensitivity to armodafinil or modafinil.
Additional clinical assessment is important for people with cardiovascular disease because increases in blood pressure and heart rate can occur. Monitoring may be appropriate in some patients.
Particular caution is also required for people with a history of:
- Psychosis
- Depression
- Mania
- Cardiovascular disease
- Previous reactions to modafinil or armodafinil
Severe liver impairment can affect medicine exposure, while older adults may eliminate armodafinil more slowly.
Pregnancy, plans to become pregnant and breastfeeding should be discussed with a healthcare professional before treatment. Patients using hormonal contraception should specifically discuss the interaction between armodafinil and contraceptive effectiveness.
Misuse and Dependence
Armodafinil has the potential for misuse. Official US prescribing information classifies it as a Schedule IV controlled substance under US federal law.
That classification should not be confused with UK controlled-drug scheduling, because US and UK drug-control systems are different.
People with a history of stimulant, medicinal or substance misuse may require additional assessment and monitoring.
Patients should take armodafinil only in the manner prescribed and should not increase the dose to enhance concentration, productivity or wakefulness.
Armodafinil should not be shared with another person or used recreationally as a so-called cognitive enhancer.
Buy Armodafinil Online in the UK
People searching to buy armodafinil online in the UK, armodafinil tablets in the UK or armodafinil online may encounter websites advertising products manufactured or supplied for overseas markets.
This requires particular caution because armodafinil should not be represented as a routinely UK-authorised medicine when current UK medicine listings do not support that description.
A medicine being available from an overseas website does not establish that the product is authorised for the UK market, appropriately manufactured, genuine or clinically suitable for the person considering it.
Unverified websites and social-media or messaging-app sellers may also provide products with uncertain ingredients, strengths, storage histories or origins.
People experiencing persistent excessive daytime sleepiness should seek an appropriate clinical assessment rather than self-diagnosing a sleep disorder and purchasing wakefulness-promoting medicines without professional involvement.
Can Armodafinil Be Bought Over the Counter in the UK?
Armodafinil should not be treated as an ordinary UK over-the-counter medicine.
Its regulatory position must also be distinguished from that of modafinil, which has UK-authorised prescription-only products for excessive sleepiness associated with narcolepsy.
The existence of overseas armodafinil products does not make them UK OTC medicines.
Anyone considering treatment for excessive daytime sleepiness should first have the cause appropriately assessed, particularly because persistent sleepiness may indicate an underlying sleep or medical disorder requiring investigation.
Buying Medicines Safely Online
When using online healthcare services, UK patients should check who is responsible for prescribing and dispensing their medicine.
Pharmacies in Great Britain can be checked using the General Pharmaceutical Council register. The Pharmaceutical Society of Northern Ireland regulates pharmacists and pharmacies in Northern Ireland.
Be cautious when a website is the following:
- Offers medicines without appropriate clinical safeguards
- Conceals the identity of the pharmacy or supplier
- Provides unclear product-origin information
- Uses social media or messaging applications for medicine sales
- Makes exaggerated claims about concentration, productivity or performance
Regulatory status should always be checked specifically for the medicine and the country in question.
How to Store Armodafinil
Storage requirements can vary according to the specific armodafinil product and manufacturer. Patients should therefore follow the instructions supplied on the packaging and accompanying medicine information rather than assuming that every product has identical storage requirements.
Medicines should be kept securely and away from children. Please verify expiry dates and avoid using expired tablets.
Unwanted medicines should not be shared or given to another person. A pharmacist can advise on appropriate disposal.
Important Safety Information
Armodafinil is a wakefulness-promoting medicine with recognised adverse effects, interactions and important safety warnings. It should not be used simply to stay awake longer, study, work extended hours or compensate for inadequate sleep.
Persistent excessive sleepiness requires appropriate investigation because the underlying cause may need separate treatment.
Patients should follow professional instructions and read the information supplied with their specific medicine.
This page provides general educational information and does not replace individual medical advice, diagnosis or treatment from a qualified healthcare professional.